(Q71614487)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

1 reference

Vachharajani NN

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Shyu WC

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Garnett WR

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Morgenthien EA

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Barbhaiya RH

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

283-294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

Multiple-dose phase I study of transnasal butorphanol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

Serum levels of butorphanol by radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

High-performance liquid chromatographic method for the quantitative determination of butorphanol, hydroxybutorphanol, and norbutorphanol in human urine using fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

Propranolol disposition in chronic liver disease: a physiological approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

Commentary: a physiological approach to hepatic drug clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

Noninvasive kinetic approach to the estimation of total hepatic blood flow and shunting in chronic liver disease--a hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

Determinants of serum antipyrine half-lives in patients with liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

The effect of hepatic disease on the disposition of moricizine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990055-7

10.1016/S0009-9236(96)90055-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8841151%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference